{"schema_version":"secwatch.filing_event.v1","accession":"0001694665-23-000027","form_type":"8-K","ticker":null,"cik":"0001694665","company_name":"Evelo Biosciences, Inc.","filed_at":"2023-03-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.176904+00:00","generated_at":"2026-06-17T23:37:27.122396+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Evelo Biosciences receives Nasdaq notice for bid price below $1; 180 days to cure","bullets":["Nasdaq letter on March 16, 2023: stock closed below $1.00 for 30 consecutive business days.","Initial compliance period ends Sept 12, 2023; must close at $1.00+ for 10 consecutive days.","If not cured, may transfer to Nasdaq Capital Market for an additional 180-day period.","Company may consider a reverse stock split, subject to board and stockholder approval."],"urls":{"canonical":"https://secwatch.observer/filing/0001694665-23-000027","json":"https://secwatch.observer/filing/0001694665-23-000027.json","markdown":"https://secwatch.observer/filing/0001694665-23-000027.md","text":"https://secwatch.observer/filing/0001694665-23-000027.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1694665/000169466523000027/0001694665-23-000027-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1694665/000169466523000027/evlo-20230316.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T23:37:27.122396+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ce0b0f1db8bcbab28ecad48f2b13178d7e56ae95","claim":"Evelo Biosciences, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).","evidence_excerpt":"March 16, 2023, Evelo Biosciences, Inc. (the “Company”) received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the last 30 consecutive business days, the bid price for the Company’s common stock, par value $0.001 per share (the “Common Stock”), had closed below the $1.00 per share minimum bid price requirement for continued inclusion on the Nasdaq Global Select Market pursuant to Nasdaq Listing Rule 5450(a)(1) (the “Bid Price Requirement”). The letter has no immediate effect on the listing of the Common Stock on th","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1694665/000169466523000027/0001694665-23-000027-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"minimum bid price"},{"label":"Rules","value":"5450(a)(1)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}